Documents
Application Sponsors
ANDA 090850 | GLAND PHARMA LTD | |
Marketing Status
Application Products
001 | INJECTABLE;INJECTION | EQ 5MG BASE/ML | 0 | MIDAZOLAM HYDROCHLORIDE | MIDAZOLAM HYDROCHLORIDE |
FDA Submissions
| ORIG | 1 | AP | 2012-01-25 | |
LABELING; Labeling | SUPPL | 2 | AP | 2012-08-28 | STANDARD |
LABELING; Labeling | SUPPL | 6 | AP | 2017-04-27 | STANDARD |
LABELING; Labeling | SUPPL | 8 | AP | 2017-04-27 | STANDARD |
LABELING; Labeling | SUPPL | 9 | AP | 2017-10-31 | STANDARD |
Submissions Property Types
ORIG | 1 | Null | 7 |
SUPPL | 2 | Null | 15 |
SUPPL | 6 | Null | 15 |
SUPPL | 8 | Null | 15 |
SUPPL | 9 | Null | 15 |
TE Codes
CDER Filings
GLAND PHARMA LTD
cder:Array
(
[0] => Array
(
[ApplNo] => 90850
[companyName] => GLAND PHARMA LTD
[docInserts] => ["",""]
[products] => [{"drugName":"MIDAZOLAM HYDROCHLORIDE","activeIngredients":"MIDAZOLAM HYDROCHLORIDE","strength":"EQ 5MG BASE\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"MIDAZOLAM HYDROCHLORIDE","submission":"MIDAZOLAM HYDROCHLORIDE","actionType":"EQ 5MG BASE\/ML","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)